Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipifarnib and Radiation Therapy in Pediatric Brainstem Glioma
NCT00079339Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2004
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tipifarnib in brainstem glioma, sponsored by National Cancer Institute. Started Jan 2004; status: completed.
02
Drugs
tipifarnib
03
Conditions
brainstem glioma
Beyond the preview
Go deeper on NCT00079339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079339.